Convex

Convex is a private, family-owned Bulgarian CRO and clinical research center that provides integrated early-phase clinical trial services within the EU regulatory framework. Its core assets include a proprietary 15-bed Phase I inpatient unit and a full-service CRO division, enabling rapid patient recruitment and streamlined operations for complex Phase I studies. With a track record of over 650 studies and 14,000 enrolled participants, the company positions itself as a cost-effective, high-quality partner for global sponsors seeking accelerated clinical development in Eastern Europe. Its strategic focus is on leveraging Bulgaria's regulatory alignment with EMA standards to deliver globally valid data for biotech, pharmaceutical, and generics companies.

Integrated clinical trial services platform combining a proprietary 15-bed Phase I inpatient clinical unit with full-service CRO capabilities. The platform leverages an extensive network of over 72 clinical sites, deep regulatory expertise with Bulgarian/EU authorities, and 35+ years of operational experience to provide end-to-end trial management from protocol to final report.

Competes with large global CROs (e.g., IQVIA, ICON) on service quality in a specific region, and with other Eastern European CROs on cost and speed. Differentiation is achieved through its owned Phase I unit (providing control and integration) and its EU regulatory standing, which offers data acceptability superior to non-EU Eastern European competitors.